Your browser doesn't support javascript.
loading
Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma.
Howarth, Peter; Quirce, Santiago; Papi, Alberto; Israel, Elliot; Mallett, Stephen; Bates, Stewart; Yancey, Steve; Albers, Frank C; Kwon, Namhee.
Afiliação
  • Howarth P; Global Medical, Global Specialty and Primary Care, GSK House, Brentford, Middlesex, UK.
  • Quirce S; Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Papi A; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
  • Israel E; Section of Cardiorespiratory and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Mallett S; S. Anna University Hospital, Ferrara, Italy.
  • Bates S; Harvard Medical School and Asthma Research Center, Brigham and Women's Hospital, Boston, MA, USA.
  • Yancey S; Biostatistics, GSK, Uxbridge, UK.
  • Albers FC; Respiratory Discovery Medicine, GSK, Stevenage, UK.
  • Kwon N; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
Allergy ; 75(8): 2085-2088, 2020 08.
Article em En | MEDLINE | ID: mdl-32147844
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article